← SynDRA
TW-37
SynDRA canonical compound SYN0050097 — structure-anchored drug synonym record
| Primary target(s) | BCL2L1 |
| Mechanism of action | BCL inhibitor |
All known targets
Mechanisms of action (all sources)
- BCL inhibitor
- BCL2 INHIBITOR
- MCL1 INHIBITOR
- BCL2L1 INHIBITOR
Cross-references
Synonyms
- FQ8NY4LUO5
- UNII-FQ8NY4LUO5
- RefChem:192611
- DTXCID40417214
- C33H35NO6S
- MFCD17010275
- MLS006010425
- tw-37?
- SCHEMBL687266
- orb1300906
- SCHEMBL29359532
- SCHEMBL29360605
- CHEBI:95008
- GLXC-03530
- HMS3651I03
- EX-A2173
- BDBM50196032
- s1121
- AKOS015966872
- CCG-264828
- CS-0155
- SB19398
- NCGC00263208-01
- NCGC00263208-05
- NCGC00263208-07
- AC-32081
- BP-25408
- CS-11194
- HY-12020
- SMR004701450
- SY008562
- SW218144-2
- T6281
- BRD-K28360340-001-01-8
- BRD-K28360340-001-05-9
- BRD-K28360340-001-08-3
- Bcl-2 Inhibitor
- N-[4-[(2-tert-Butylphenyl)sulfonyl]phenyl]-2,3,4-trihydroxy-5-[(2-isopropylphenyl)methyl]benzamide
- N-[4-(2-tert-butylphenyl)sulfonylphenyl]-2,3,4-trihydroxy-5-[(2-propan-2-ylphenyl)methyl]benzamide
Look up TW-37 in the interactive SynDRA portal →